Amgen profit tops Street view, boosts full-year forecast
July 30, 2015 at 16:14 PM EDT
(Reuters) - Amgen Inc on Thursday reported higher-than-expected second quarter profit and revenue, helped by strong sales of its Enbrel rheumatoid arthritis drug and cost cutting, and the company raised its full-year forecasts.